Showing results (71-80 of 247) with videos related to

Sort By:
Pageof 25
American Journal of Ophthalmology Case Reports|August 8, 2024
Intravitreal anti-vascular endothelial growth factor therapy in the treatment of vision loss associated with hematologic malignancyThomas P Toohey, Jake Shortt, Nevin John, et al.
Nature Reviews. Cancer|October 22, 2021
Targeting transcription cycles in cancerStephin J Vervoort, Jennifer R Devlin, Nicholas Kwiatkowski, et al.
International Journal of Cancer|April 30, 2002
Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cellsAstrid A Ruefli, David Bernhard, Kellie M Tainton, et al.
Immunity|February 28, 2012
Constitutive type I interferon modulates homeostatic balance through tonic signalingDaniel J Gough, Nicole L Messina, Christopher J P Clarke, et al.
European Journal of Haematology|December 20, 2023
Use of platelet transfusions and tranexamic acid in patients with myelodysplastic syndromes: A clinical practice surveyAllison Mo, Robert Weinkove, Erica M Wood, et al.
Cell Reports|August 17, 2022
Inhibition of mutant IDH1 promotes cycling of acute myeloid leukemia stem cellsEmily Gruber, Joan So, Alexander C Lewis, et al.
European Journal of Haematology|April 8, 2021
Risk factors for invasive fungal infection in 5-azacytidine treated patients with acute myeloid leukemia and myelodysplastic syndromeAmanda Tey, Briony Shaw, Luke Cardamone, et al.
Cancer Discovery|December 18, 2012
The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescenceMeaghan Wall, Gretchen Poortinga, Kym L Stanley, et al.
Clinical Epigenetics|November 19, 2020
Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemiaJessica M Salmon, Michael Bots, Eva Vidacs, et al.
Clinical Epigenetics|January 29, 2015
Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemiaJessica M Salmon, Michael Bots, Eva Vidacs, et al.
Pageof 25